Illumina Puts More Funding Into 23AndMe

San Diego-based DNA sequencing equipment maker Illumina has joined in a new venture funding round for high profile, genetic testing startup 23andMe. 23andMe said this morning that it has raised $115M in a Series E funding round, which was led by Fidelity Management & Research Company, and also included Casdin Capital, WuXi Healthcare Ventures and Xfund, plus Illumina, New Enterprise Associates, MPM Capital, and Google Ventures. Illumina is a prior investor in 23andMe, which provides personalized genetic testing services. 23andMe has now raised over $200M in funding. More information »